1:39 PM
 | 
Dec 06, 2018
 |  BC Extra  |  Financial News

Angina gene therapy company XyloCor raises $17M series A round

Gene therapy company XyloCor Therapeutics Inc. (Philadelphia, Pa.) raised $17 million in a series A round led by Sofinnova Ventures and Life Science Partners.

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >